HIV Testing Pre- and Post-COVID-19 Pandemic Among Persons who Inject Drugs – National HIV Behavioral Surveillance, 19 Cities, 2018 and 2022
AIDS and Behavior · 2025
DOI: 10.1007/s10461-025-04672-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS and Behavior, 2025. Verfasst von Rebecca B Hershow und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA…. Hauptthemen laut MEDLINE: Substance Abuse, Intravenous, COVID-19, HIV Infections, HIV Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
HIV testing decreased during the COVID-19 pandemic among persons who inject drugs (PWID), though it is unclear how these changes in HIV testing affected different sub-groups of PWID. We estimated the change in past-year HIV testing between 2018 and 2022 overall and by sociodemographic and health care characteristics among PWID. Past-year HIV testing significantly decreased between 2018 and 2022 overall and across most sub-groups of PWID, including PWID accessing and not accessing medical and harm reduction services. Integrating HIV testing across medical and harm reduction services accessed by PWID and expanding community-based HIV testing might increase HIV testing among PWID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. Qdt8@cdc.gov.
- Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Förderung
- Intramural CDC HHS
Zitieren
APA
Hershow, R. B., Broz, D., Faucher, L., Feelemyer, J., Chapin-Bardales, J., & National HIV Behavioral Surveillance Study Group (2025). HIV Testing Pre- and Post-COVID-19 Pandemic Among Persons who Inject Drugs – National HIV Behavioral Surveillance, 19 Cities, 2018 and 2022. AIDS and Behavior. https://doi.org/10.1007/s10461-025-04672-4
Vancouver
Hershow RB, Broz D, Faucher L, Feelemyer J, Chapin-Bardales J, National HIV Behavioral Surveillance Study Group. HIV Testing Pre- and Post-COVID-19 Pandemic Among Persons who Inject Drugs – National HIV Behavioral Surveillance, 19 Cities, 2018 and 2022. AIDS and Behavior. 2025. doi:10.1007/s10461-025-04672-4
BibTeX
@article{Hershow2025,
author = {Hershow, Rebecca B and Broz, Dita and Faucher, Lyssa and Feelemyer, Jonathan and Chapin-Bardales, Johanna and National HIV Behavioral Surveillance Study Group, National HIV Behavioral Surveillance Study Group},
title = {HIV Testing Pre- and Post-COVID-19 Pandemic Among Persons who Inject Drugs – National HIV Behavioral Surveillance, 19 Cities, 2018 and 2022},
journal = {AIDS and Behavior},
year = {2025},
doi = {10.1007/s10461-025-04672-4}
}
EUVIMED